The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | Future biomarkers for MDS
The NLRP3 inflammasome initiates cell death by inducing pyroptosis, the inflammatory form of cell death. Here, Alan List, MD, of Moffitt Cancer Center, Tampa, FL, discusses the quantification of oxidized DNA, released from this cell lysis, as a biomarker of disease activity and emerging treatment response for myelodysplastic syndrome (MDS). This interview was recorded at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
